Skip to main content

Table 1 Sociodemographic and clinical characteristics of the notified TB cases (n = 1553) among the refugee camps in Ethiopia, 2014–2017

From: Tuberculosis (TB) in the refugee camps in Ethiopia: trends of case notification, profile, and treatment outcomes, 2014 to 2017

Characteristic

2014,

N (%)

2015,

N (%)

2016,

N (%)

2017,

N (%)

Total

N (%)

Total TB cases of all Forms

138

354

473

588

1553

Age group

  < 15

26 (18.8)

92 (26.0)

135 (28.5)

177 (30.1)

430 (27.7)

 15–29

50 (36.2)

107 (30.2)

141 (29.8)

152 (25.9)

450 (29.0)

 30–44

39 (28.3)

87 (24.6)

107 (22.6)

132 (22.4)

365 (23.5)

 45–59

15 (10.9)

43 (12.1)

46 (9.7)

79 (13.4)

183 (11.8)

  > = 60

6 (4.3)

23 (6.5)

39 (8.3)

44 (7.5)

112 (7.2)

 Not documented

3 (2.2)

2 (0.6)

4 (1.0)

4 (0.7)

13 (0.8)

Mean age, years

28.0

27.1

26.8

27.0

27.2

Sex

 Male

80 (58.0)

193 (54.5)

247 (52.2)

330 (56.1)

850 (54.7)

 Female

57 (41.3)

160 (45.2)

222 (46.9)

251 (42.7)

690 (44.4)

 Not documented

1 (0.7)

1 (0.3)

4 (0.9)

7 (1.2)

13 (0.8)

Type of TB

 PTB

106 (76.8)

279 (78.8)

334 (70.6)

389 (66.2)

1108 (71.3)

 EPTB

32 (23.2)

73 (20.6)

134 (28.3)

192 (32.7)

431 (27.8)

 Not documented

0

2 (0.6)

5 (1.1)

7 (1.1)

14 (0.9)

Type of TB by diagnostic category

 PTB+

47 (34.0)

162 (45.8)

216 (45.7)

252 (42.9)

677 (43.6)

 Clinically diagnosed PTBa

59 (42.8)

117 (33.1)

118 (25.0)

137 (23.3)

431 (27.7)

 EPTB

32 (23.2)

73 (20.6)

134 (28.3)

192 (32.6)

431 (27.8)

 Not documented

0

2 (0.5)

5 (1.0)

7 (1.2)

14 (0.9)

TB patient by previous treatment history:

 New and relapseb

137 (99.3)

347 (98.0)

462 (97.7)

581 (98.8)

1527 (98.3)

 Treatment after Failure

0

0

1 (0.2)

1 (0.2)

2 (0.1)

 Lost to Follow up to Treatment

1 (0.7)

3 (0.8)

5 (1.1)

4 (0.6)

13 (0.8)

 Others

0

1 (0.3)

2 (0.4)

1 (0.2)

4 (0.3)

 Not documented

0

3 (0.8)

3 (0.6)

1 (0.2)

7 (0.5)

New and relapse PTB patients:

105 (76.6)

276 (80.4)

328 (71.0)

384 (66.1)

1093 (71.6)

 Bacteriologically confirmed cases:

46 (43.8)

161 (58.3)

210 (64.0)

249 (64.8)

666 (60.9)

 Clinically diagnosed cases:

59 (56.2)

115 (41.7)

118 (36.0)

135 (35.2)

427 (39.1)

HIV status

 Positive

10 (8.6)

48 (15.3)

50 (13.2)

57 (10.9)

165 (10.6)

 Negative

106 (91.4)

265 (84.7)

329 (86.8)

464 (89.1)

1164 (75.0)

 Not documented

22 (15.9)

41 (11.6)

94 (26.6)

67 (11.4)

224 (14.4)

ART initiation

 Yes

4 (40.0)

44 (91.7)

38 (76.0)

48 (84.2)

134 (81.2)

 No

6 (60.0)

4 (8.3)

12 (24.0)

9 (15.8)

31 (18.8)

TB cases by refugee areas

 Shire

21 (15.2)

28 (7.9)

26 (5.5)

28 (4.8)

103 (6.6)

 Afar

0

0

6 (1.3)

47 (8.0)

53 (3.4)

 Gambella

43 (31.2)

159 (44.9)

288 (60.9)

368 (62.6)

858 (55.2)

 Mizan

2 (1.4)

30 (8.5)

18 (3.8)

29 (4.9)

79 (5.1)

 Asossa

14 (10.1)

29 (8.2)

16 (3.4)

14 (2.4)

73 (4.7)

 Jijiga

45 (32.6)

42 (11.9)

45 (9.5)

34 (5.8)

166 (10.7)

 Dollo Ado

13 (9.4)

66 (18.6)

74 (15.6)

68 (11.6)

221 (14.2)

  1. PTB+ Smear-positive pulmonary TB
  2. aClinically diagnosed PTB: includes smear-negative pulmonary TB and pulmonary smear unknown/not done
  3. bNew and relapse: includes cases for which the treatment history is unknown (not recorded) and transfer in; and it excludes cases that have been re-registered as treatment after failure, as treatment after lost to follow up or as other previously treated with unknown or undocumented treatment outcome